Mass General Neurology is pleased to announce that Grace Croty, MD has received a 2022 Clinical Research Training Scholarship in Parkinson's Disease, funded by the Parkinson's Foundation and American Brain Foundation, in collaboration with the American Academy of Neurology.
Situated among one of the world’s largest neuroscience communities, the Massachusetts General Hospital provides an array of neurotherapeutic treatments for our varied patient populations. Experts from the Department of Neurology, Department of Neurosurgery, Department of Psychiatry, the Athinoula A. Martinos Center for Biomedical Imaging and beyond develop and implement neurotherapeutics and associated diagnostics for individuals with complex brain disorders affecting cognition, behavior, emotion, sensory and motor functioning.
The ALS Multidisciplinary Clinic in the Healey Center for ALS at Mass General provides personalized care and access to the latest treatments and research opportunities for people with ALS, commonly known as Lou Gehrig’s disease.
Center for Bipolar Treatment Innovation
The Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital is dedicated to finding new treatments for bipolar disorder, providing high-quality clinical care and educating our colleagues, our patients, their families and the community about this disorder.
Electroconvulsive Therapy (ECT)
We use Electroconvulsive Therapy (ECT) to treat a number of psychiatric conditions, including depression.
The Mass General Epilepsy Service offers diagnosis, treatment, and consultations for seizure disorders, including surgical evaluations, and specialized care for first seizure events.
Functional Neurosurgery Center
Our neurosurgeons use deep brain stimulation (DBS) to treat patients with a wide variety of movement disorders.
The Intravenous (IV) Ketamine Clinic for Depression at Massachusetts General Hospital offers patients and their professional providers access to ketamine treatment for severe and refractory depression.
Movement Disorders Unit
The Movement Disorders Unit at Mass General sees patients from around the world for everything from the most common to the rarest of movement disorders.
Parkinson's Disease Cell Therapy
For several decades the Massachusetts General Hospital Department of Neurosurgery and Department of Neurology have led in patient care for those with Parkinson's disease and advancing clinical research to develop new treatments with the hope of creating a cure.
Though Parkinson's disease is the most common form of a group of motor system disorders known as parkinsonism
The MassGeneral Hospital for Children Epilepsy Surgery Program provides surgical evaluation and treatment for pediatric patients whose epilepsy cannot be managed with medical therapy or those for whom surgery is the best option overall.
The mission of the Pediatric Psychopharmacology and Adult ADHD Program at Massachusetts General Hospital is to advance the well-being of children and families afflicted with mental illness through research, education and clinical care.
The TMS Clinical Service at Massachusetts General Hospital provides non-invasive treatment for patients with major depressive disorder who are unable to find relief through antidepressant medications or psychotherapy.
The ATRC in the Department of Neurology at Massachusetts General Hospital serves as a molecular and anatomic neuropathology resource for the Boston neuroscience community.
Massachusetts General Hospital provides deep brain stimulation as a treatment for a variety of neurological disorders, including XDP.
Our mission is to drive the development of new mechanism-driven therapies through a richer understanding of how neurologic disease affects behavior.
Our lab, led by Bakhos Tannous, PhD, focuses on molecular imaging, gene transfer technologies and high throughput screening aiming at finding novel therapeutics against brain tumors.
The Microfluidics Core provides know-how and state-of-the-art facilities for investigators in nervous system development, function, and dysfunction, to measure, control, and perturb the cellular microenvironment at the scale comparable to cell size.
The Multiphoton Imaging Core is part of the Neurosciences Center at Massachusetts General Hospital. The technology of multiphoton microscopy allows imaging of visible light fluorophores.
The Division of Neurotherapeutics at Mass General focuses on neurotherapeutic interventions for severe, treatment-resistant psychiatric illnesses.
The Neurotherapeutics Program at Massachusetts General Hospital encompasses the clinical, research and training activities related to device-based treatments for psychiatric disorders.
Our lab is focused on understanding neural repair mechanisms and outcomes after stroke in order to guide the development and clinical translation of novel neurotechnologies to optimize stroke recovery.
The Visual Prosthesis Lab is working to create a means to restore sight to the blind by sending signals from a digital camera directly into the brain.
Related News and Articles
- Jun | 14 | 2022
Mass General researchers are testing how medical marijuana usage impacts mental health outcomes.
- Jun | 14 | 2022
Conversations on Mental Health: Sharmin Ghaznavi, MD, PhD, & The Center for the Neuroscience of Psychedelics
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
- Jun | 14 | 2022
TEMPOS is a user-friendly rating scale that can be used to assess adherence to reporting recommendations.
- Jun | 14 | 2022
Last week, the US Food and Drug Administration’s (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) unanimously endorsed a new therapy for early active cerebral adrenoleukodystrophy (CALD).
- Jun | 10 | 2022
The Sean. M. Healey & AMG Center for ALS at Massachusetts General Hospital is accepting nominations for the 2022 Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing in acknowledgement of the important scientific work being done in ALS.